If you’d invested £1,000 in the RBS share price a year ago, this is how much it would be worth today

An investment in RBS has been surprisingly lucrative over the past 12 months as this Fool explains.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The RBS (LSE: RBS) share price has been a pretty poor investment to own over the past five years.

Indeed, since the end of 2014, shares in the bank have underperformed the FTSE 100 by a shocking 14% per annum, including dividends.

However, over the past 12 months, RBS’s performance has improved dramatically.

Shares in the bank have returned 21.4% since the end of December 2018, outperforming the FTSE 100 by around 10%. These numbers imply that if you’d invested £1,000 in the share price this time last year, your investment would be worth £1,243 today. The same investment in the FTSE 100 would be worth just £1,170.

The question is, can this outperformance continue or is it time to give up on the RBS share price?

Growth ahead

It is a bit difficult to tell what the future holds for the share price until the result of the general election becomes clear at the end of this week.

A Labour majority could spell disaster for the bank and its peers as the party has continuously promised to target the financial sector if it gets into power. On the other hand, the Tories are promising to “get Brexit done” with Boris Johnson’s current deal, which might hurt the financial sector, but most analysts believe Labour’s plans will be more damaging. 

Based on current polling, it looks as if Johnson is going to win the contest, which could be good news for the share price based on Labour’s rhetoric regarding the financial sector.

Although Johnson’s Brexit deal could hurt the bank in the short term, over the long run, I think the future is bright for RBS.

And based on the bank’s current valuation, even after its recent performance, the stock looks cheap to me at current levels.

Undervalued

City analysts currently believe that RBS is set to earn 23.8p per share for 2019, putting the stock on a forward P/E of 9.7. On top of this, analysts have the company distributing a total of 22.9p per share in dividends, giving a dividend yield of 9.9% on the current share price.

Further growth is expected in 2020. The stock is trading at a 2020 P/E of 9.4 according to current projections, although the dividend yield is expected to slump to 6.5%.

Still, these are just preliminary estimates. As RBS has recently shown us, it is willing to offer investors a special dividend when the time is right. On that basis, I wouldn’t rule out another special payout next year if the bank meets or beats profit expectations.

The bottom line

So overall, I think the RBS share price still offers value even after its performance over the last 12 months.

The bank has come a long way from its crisis bailout. Now management has returned the group to profit and reinstated its dividend, earnings growth is on the cards. As long as there are no severe economic shocks over the next 12 months, I think investors could be well rewarded in 2020.

Rupert Hargreaves owns no share mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »